Dabrafenib Mesylate and Dextroamphetamine Sustained-Release Capsules
Determining the interaction of Dabrafenib Mesylate and Dextroamphetamine Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: dextroamphetamine
Brand name: Dexedrine Spansule, ProCentra, Zenzedi, Dexedrine, Dextrostat, Liquadd
Synonyms: Dextroamphetamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Dextroamphetamine Tablets
- Dabrafenib Mesylate-Dextromethorphan
- Dabrafenib Mesylate-Dextromethorphan and Chlorpheniramine Chewable Tablets
- Dabrafenib Mesylate-Dextromethorphan and Chlorpheniramine Liquid and Syrup
- Dabrafenib Mesylate-Dextromethorphan and Chlorpheniramine Tablets
- Dabrafenib Mesylate-Dextromethorphan and doxylamine
- Dextroamphetamine Sustained-Release Capsules-Dacarbazine
- Dextroamphetamine Sustained-Release Capsules-Dacarbazine Intravenous, Injection
- Dextroamphetamine Sustained-Release Capsules-Daclatasvir
- Dextroamphetamine Sustained-Release Capsules-Daclatasvir Dihydrochloride
- Dextroamphetamine Sustained-Release Capsules-Daclizumab
- Dextroamphetamine Sustained-Release Capsules-Daclizumab Subcutaneous